EVELUT®: dyspnoea and symptom burden in COPD patients switching from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS

被引：0
|
作者：
Buhl, R. [1 ]
Dreher, M. [2 ]
Mattiucci-Guehlke, M. [3 ]
Eckhardt, S. [4 ]
Taube, C. [5 ]
Vogelmeier, C. [6 ]
Buhl, R. [1 ]
机构：
[1] Mainz Univ Hosp, Dept Pulm, Mainz, Germany
[2] Univ Hosp RWTH, Dept Pneumol & Intens Care Med, Aachen, Germany
[3] Boehringer Ingelheim Pharma GmbH & Co KG, HP Country Med Affairs, Ingelheim, Germany
[4] Alcedis GmbH, Giessen, Germany
[5] Univ Duisburg Essen, Univ Hosp Essen, Dept Pulm Med, Ruhrlandklin, Essen, Germany
[6] Univ Med Ctr, Dept Med Pulm & Crit Care Med, Marburg, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.3023
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3023
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Buhl, Roland
    Dreher, Michael
    Mattiucci-Guehlke, Muriel
    Emerson-Stadler, Rachel
    Eckhardt, Sebastian
    Taube, Christian
    Vogelmeier, Claus F.
    [J]. ADVANCES IN THERAPY, 2023, 40 (07) : 3263 - 3278
  • [2] EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Roland Buhl
    Michael Dreher
    Muriel Mattiucci-Guehlke
    Rachel Emerson-Stadler
    Sebastian Eckhardt
    Christian Taube
    Claus F. Vogelmeier
    [J]. Advances in Therapy, 2023, 40 : 3263 - 3278
  • [3] LAMA/LABA oder LABA/ICS?
    Michael Hubert
    [J]. MMW - Fortschritte der Medizin, 2015, 157 (14) : 76 - 76
  • [4] ICS/LABA/LAMA wirksamer als LABA/LAMA
    Fath R.
    [J]. MMW - Fortschritte der Medizin, 2018, 160 (18) : 69 - 69
  • [5] Step up to ICS/LAMA/LABA vs switch to LAMA/LABA in patients with COPD on ICS/LABA: post hoc analysis of KRONOS
    Singh, Dave
    Bafadhel, Mona
    Bowen, Karin
    Arya, Niki
    Marshall, Jonathan
    Parikh, Himanshu
    Patel, Mehul
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [6] COMPARISON OF LAMA/LABA AND ICS/LABA AS INITIAL TREATMENT FOR COPD
    Aoyama, Junichi
    Tanaka, Yosuke
    Kosaihira, Seiji
    Okano, Tetuya
    Hino, Mitunori
    Seike, Masahiro
    Gemma, Akihiko
    [J]. RESPIROLOGY, 2019, 24 : 165 - 165
  • [7] Exacerbation outcomes with LAMA/LABA and ICS/LABA in high risk COPD patients in the IMPACT trial
    Lipson, David A.
    Barnhart, Frank
    Boucot, Isabelle
    Crim, Courtney
    Brealey, Noushin
    Criner, Gerard J.
    Dransfield, Mark
    Halpin, David M. G.
    Kilbride, Sally
    Han, Meilan K.
    Lange, Peter
    Lomas, David A.
    Martinez, Fernando J.
    Singh, Dave
    Naya, Ian Naya
    Jones, Christine Elaine
    Wise, Robert
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [8] EFFECTIVENESS OF COPD MAINTENANCE THERAPY WITH LAMA/LABA VS LAMA/LABA/ICS IN A UNITED STATES CLAIMS DATABASE
    Quint, Jennifer
    Montonen, Jukka
    He, Xintong
    de la Hoz, Alberto
    Esposito, Daina
    [J]. CHEST, 2021, 160 (04) : 1863A - 1864A
  • [9] LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
    Hizawa, Nobuyuki
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1093 - 1102
  • [10] LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
    Rodrigo, Gustavo J.
    Price, David
    Anzueto, Antonio
    Singh, Dave
    Altman, Pablo
    Bader, Giovanni
    Patalano, Francesco
    Fogel, Robert
    Kostikas, Konstantinos
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 907 - 922
12345